The investigations for improving successful judgment rate with PillCam Patency Capsule and differential diagnosis in Crohn's disease patients with following capsule endoscopy.

The investigations for improving successful judgment rate with PillCam Patency Capsule and differential diagnosis in Crohn's disease patients with following capsule endoscopy. - IMPULSE Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008199

Enrollment

Registered

2012-06-19

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

Patients administered with mosapride Patients administered with no mosapride

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as Crohn's disease according to diagnostic criteria Patients who were taking NSAIDs or aspirin more than 3 months

Exclusion criteria

Exclusion criteria: short bowel syndrome, less than once a 3 days defecation as constipation

Design outcomes

Primary

Measure	Time frame
1) The rate of confirming functional patency by PillCam Patency Capsule 2) The rate of endoscopic diagnosis for Crohn's disease by capsule endoscopy	—

Countries

Japan

Contacts

Public ContactKenji Watanabe

Graduate School of Medicine, Osaka City University Gastroenterology

kenjiw1779@gmail.com06-6645-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

The investigations for improving successful judgment rate with PillCam Patency Capsule and differential diagnosis in Crohn&#39;s disease patients with following capsule endoscopy.